| Literature DB >> 26919418 |
Aleksandar Sekulic1, Daniel Von Hoff2.
Abstract
The hedgehog (Hh) signaling pathway is aberrantly activated in a majority of basal cell carcinomas (BCC). Vismodegib and sonidegib are targeted inhibitors of Smoothened (SMO). Both drugs are approved for use in locally advanced BCC (laBCC), with vismodegib also approved for metastatic BCC (mBCC).Entities:
Mesh:
Substances:
Year: 2016 PMID: 26919418 DOI: 10.1016/j.cell.2016.02.021
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582